We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BBC market cap is 10.95M. The company's latest EPS is USD -9.0267 and P/E is -2.70.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 82k | 146k | 114k | 50k | 132k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -735k | 11.39M | 5.55M | -14.99M | -4.06M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 26.9M | 40.71M | 38.74M | 19.58M | 8.69M |
| Total Liabilities | 3.13M | 3.7M | 3.25M | 1.46M | 653k |
| Total Equity | 23.78M | 37.02M | 35.49M | 18.12M | 8.04M |
| Market Cap | 10.95M |
| Price to Earnings Ratio | -2.70 |
| Price to Sales Ratio | 83.09 |
| Price to Cash Ratio | 39.88 |
| Price to Book Ratio | 1.36 |
| Dividend Yield | - |
| Shares Outstanding | 450k |
| Average Volume (1 week) | 2.41k |
| Average Volume (1 Month) | 2.99k |
| 52 Week Change | -0.89% |
| 52 Week High | 31.99 |
| 52 Week Low | 23.66 |
| Spread (Intraday) | 1.48 (5.93%) |
| Company Name | Virtus LifeSci Biotech Clinical Trials ETF |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
